⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for defactinib hydrochloride

Every month we try and update this database with for defactinib hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)NCT04439331
Advanced Lympho...
Advanced Malign...
Hematopoietic a...
Refractory Lymp...
Refractory Mali...
Refractory Mult...
Defactinib Hydr...
18 Years - National Cancer Institute (NCI)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)NCT02465060
Advanced Lympho...
Advanced Malign...
Bladder Carcino...
Breast Carcinom...
Cervical Carcin...
Colon Carcinoma
Colorectal Carc...
Endometrial Car...
Esophageal Carc...
Gastric Carcino...
Glioma
Head and Neck C...
Hematopoietic a...
Kidney Carcinom...
Liver Carcinoma
Lung Carcinoma
Lymphoma
Malignant Uteri...
Melanoma
Multiple Myelom...
Ovarian Carcino...
Pancreatic Carc...
Prostate Carcin...
Rectal Carcinom...
Recurrent Bladd...
Recurrent Breas...
Recurrent Cervi...
Recurrent Colon...
Recurrent Color...
Recurrent Esoph...
Recurrent Gastr...
Recurrent Gliom...
Recurrent Head ...
Recurrent Liver...
Recurrent Lung ...
Recurrent Lymph...
Recurrent Malig...
Recurrent Melan...
Recurrent Multi...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Prost...
Recurrent Recta...
Recurrent Skin ...
Recurrent Thyro...
Recurrent Uteri...
Refractory Lymp...
Refractory Mali...
Refractory Mult...
Skin Carcinoma
Thyroid Gland C...
Uterine Corpus ...
Adavosertib
Afatinib
Afatinib Dimale...
Binimetinib
Biopsy
Biospecimen Col...
Capivasertib
Computed Tomogr...
Copanlisib
Copanlisib Hydr...
Crizotinib
Cytology Specim...
Dabrafenib
Dabrafenib Mesy...
Dasatinib
Defactinib
Defactinib Hydr...
Echocardiograph...
Erdafitinib
Fexagratinib
Ipatasertib
Laboratory Biom...
Larotrectinib
Larotrectinib S...
Magnetic Resona...
Multigated Acqu...
Nivolumab
Osimertinib
Palbociclib
Pertuzumab
PI3K-beta Inhib...
Radiologic Exam...
Radionuclide Im...
Relatlimab
Sapanisertib
Sunitinib Malat...
Taselisib
Trametinib
Trastuzumab
Trastuzumab Emt...
Ulixertinib
Vismodegib
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: